Afoxolaner Powder CAS 1093861-60-9 for Dogs Afoxolaner

Product Details
Customization: Available
Powder: Yes
Customized: Customized
Still deciding? Get samples of $ !
Request Sample
Diamond Member Since 2019

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Importers and Exporters
The supplier has import and export rights
Experienced Team
The supplier has 12 foreign trading staff(s) and 10 staff(s) with over 6 years of overseas trading experience
In-stock Capacity
The supplier has In-stock capacity
Fast Delivery
The supplier can deliver the goods within 15 days
to see all verified strength labels (12)
  • Afoxolaner Powder CAS 1093861-60-9 for Dogs Afoxolaner
  • Afoxolaner Powder CAS 1093861-60-9 for Dogs Afoxolaner
  • Afoxolaner Powder CAS 1093861-60-9 for Dogs Afoxolaner
  • Afoxolaner Powder CAS 1093861-60-9 for Dogs Afoxolaner
  • Afoxolaner Powder CAS 1093861-60-9 for Dogs Afoxolaner
  • Afoxolaner Powder CAS 1093861-60-9 for Dogs Afoxolaner
Find Similar Products
  • Overview
  • Description
  • COA
  • Application & Funtion
  • Company
Overview

Basic Info.

Model NO.
SENTIAN-Afoxolaner
Certification
ISO 9001, FDA
Suitable for
Adult
State
Powder
Purity
>99%
Shelf Life
2 Years
MOQ
1kg
Use
for Dogs
Molecular Formula
C26h17clf9n3o3
Molecular Weight
625.87000
Transport Package
1kg/Bag, 25kg/Drum
Specification
99%
Trademark
SENTIAN
Origin
China
Production Capacity
5000kg Per Month

Product Description


 

Description

 
product name Afoxolaner 
CAS NO. 1093861-60-9
Specification 99%
Appearance white powder
Package 1KG/Bag,5kg/bag,25kg/drum
MOQ 1KG


Basic information
Chemical name: 4-[5-[3-chloro-5-(trifluoromethyl)phenyl]-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-N-[2-oxo-2-[(2,2,2-trifluoroethyl)amino]ethyl]-1-naphthamide

CAS number: 1093861-60-9
Molecular formula: C26H17ClF9N3O3
Molecular weight: 625.87

COA

 

Items Standards Results
Appearance white powder Complies
Specification 99% 99.20%
Loss on Drying ≤ 5.0% Complies
Heavy Metal ≤ 10.0 mg/kg Complies
Pb ≤ 2.0 mg/kg Complies
As ≤ 1.0 mg/kg Complies
Hg ≤ 0.1 mg/kg Complies
Total Plate Count ≤ 1000cfu/g Complies
Yeast&Mold ≤ 100cfu/g Complies
E.coil Negative Negative
Salmonella Negative Negative
Conclusion: in conformity with the enterprise standard

Application & Funtion

Pharmacological action
Afoxolaner blocks the transmission of chloride ions from the presynaptic membrane to the postsynaptic membrane by acting on ligand-gated chloride ion channels, especially inhibiting channels gated by the neurotransmitter γ-aminobutyric acid (GABA), resulting in increased activity of insect neurons and death due to excessive excitement.
This mechanism enables Afoxolaner to effectively kill fleas and ticks.

Clinical Applications
Afoxolaner is mainly used to treat flea and tick infestations in dogs. Specific applications include:

Flea infestation: kill fleas within 8 hours.
Tick infestation: kill ticks within 48 hours.
Mite infestation: treat canine mite infestations (such as canine scabies and canine demodex).

Dosage and Usage
Afoxolaner is usually used in the form of chewable tablets, and the specific usage is as follows:

Dosage for dogs: Administer according to body weight, with a dose range of 2.7mg/kg to 7.0mg/kg. Administer once a month, adjusted according to epidemiological conditions.

Treatment of scabies infestation: Administer once a month, twice in a row, and the administration time can be extended if necessary

 

Company

Afoxolaner Powder CAS 1093861-60-9 for Dogs AfoxolanerAfoxolaner Powder CAS 1093861-60-9 for Dogs AfoxolanerAfoxolaner Powder CAS 1093861-60-9 for Dogs AfoxolanerAfoxolaner Powder CAS 1093861-60-9 for Dogs AfoxolanerAfoxolaner Powder CAS 1093861-60-9 for Dogs AfoxolanerAfoxolaner Powder CAS 1093861-60-9 for Dogs Afoxolaner

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier